Cubist Systematic Strategies LLC Takes $369,000 Position in LENSAR, Inc. $LNSR

Cubist Systematic Strategies LLC purchased a new stake in shares of LENSAR, Inc. (NASDAQ:LNSR) during the first quarter, HoldingsChannel.com reports. The fund purchased 26,136 shares of the company’s stock, valued at approximately $369,000.

A number of other institutional investors also recently bought and sold shares of LNSR. Gabelli Funds LLC bought a new position in LENSAR in the first quarter valued at about $191,000. Nuveen LLC bought a new position in LENSAR in the first quarter valued at about $252,000. Virtu Financial LLC bought a new position in LENSAR in the first quarter valued at about $407,000. Tabor Asset Management LP bought a new position in LENSAR in the first quarter valued at about $452,000. Finally, Draper Asset Management LLC bought a new stake in LENSAR during the first quarter valued at approximately $565,000. Institutional investors own 40.15% of the company’s stock.

LENSAR Stock Performance

Shares of NASDAQ LNSR opened at $12.13 on Friday. The firm has a 50 day moving average of $12.75 and a 200 day moving average of $13.31. The firm has a market capitalization of $144.83 million, a price-to-earnings ratio of -2.88 and a beta of 0.49. LENSAR, Inc. has a 12-month low of $3.80 and a 12-month high of $17.31.

LENSAR (NASDAQ:LNSR) last announced its earnings results on Thursday, August 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.07). The business had revenue of $11.36 million for the quarter, compared to the consensus estimate of $16.55 million. LENSAR had a negative net margin of 84.49% and a negative return on equity of 737.30%.

LENSAR Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.